HEATHER WATERS: Open Payments
NPI 1801463203 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 37 payments from 15 companies in 2025. Trend: 2023 $331 · 2024 $560 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $172 |
| ABBVIE INC. | 6 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| Amgen Inc. | 4 | $66 |
| Lilly USA, LLC | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Novo Nordisk Inc | 2 | $46 |
| PFIZER INC. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: FARXIGA, VRAYLAR, CAPLYTA, EVENITY, XIFAXAN, AIRSUPRA, BREZTRI, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
